| 10.6 |
63.8 |
GO:0002225 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 9.7 |
38.9 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 9.5 |
28.4 |
GO:1902173 |
negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 7.0 |
28.0 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 6.3 |
18.8 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 4.2 |
12.7 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 4.2 |
4.2 |
GO:0002784 |
regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 3.7 |
11.0 |
GO:1904300 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 3.5 |
10.4 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 3.3 |
10.0 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 3.3 |
3.3 |
GO:0018277 |
protein deamination(GO:0018277) |
| 3.2 |
12.7 |
GO:0051710 |
regulation of cytolysis in other organism(GO:0051710) |
| 3.1 |
9.4 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 3.1 |
15.6 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 2.9 |
14.7 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 2.8 |
11.0 |
GO:0060901 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 2.7 |
19.0 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 2.5 |
92.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 2.5 |
9.9 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 2.5 |
12.4 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 2.5 |
44.4 |
GO:0015816 |
glycine transport(GO:0015816) |
| 2.4 |
16.8 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 2.4 |
14.1 |
GO:1902957 |
negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 2.3 |
6.9 |
GO:1904235 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 2.3 |
2.3 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 2.3 |
6.8 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 2.3 |
6.8 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 2.2 |
2.2 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 2.2 |
8.8 |
GO:0031049 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 2.2 |
17.5 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 2.1 |
8.6 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 2.1 |
25.5 |
GO:0070487 |
monocyte aggregation(GO:0070487) |
| 2.0 |
18.2 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 2.0 |
5.9 |
GO:0070175 |
positive regulation of enamel mineralization(GO:0070175) |
| 1.9 |
36.7 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.8 |
10.9 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 1.8 |
5.3 |
GO:0033242 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.7 |
33.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 1.7 |
8.7 |
GO:1903906 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 1.7 |
1.7 |
GO:1900229 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 1.7 |
5.0 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 1.7 |
14.9 |
GO:0032345 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.6 |
4.9 |
GO:0060545 |
positive regulation of necroptotic process(GO:0060545) |
| 1.6 |
4.9 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 1.6 |
8.2 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.6 |
11.4 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.6 |
6.5 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 1.6 |
6.5 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 1.6 |
12.9 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 1.6 |
4.7 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 1.6 |
4.7 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.6 |
4.7 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 1.6 |
6.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 1.5 |
6.2 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 1.5 |
7.7 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 1.5 |
9.2 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 1.5 |
6.1 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 1.5 |
3.0 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 1.5 |
8.9 |
GO:1904209 |
regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 1.4 |
10.1 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.4 |
10.0 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 1.4 |
2.9 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.4 |
4.3 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.4 |
8.4 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 1.4 |
4.2 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.4 |
2.7 |
GO:0002588 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.4 |
2.7 |
GO:1903203 |
regulation of oxidative stress-induced neuron death(GO:1903203) |
| 1.4 |
8.2 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 1.4 |
4.1 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 1.3 |
4.0 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 1.3 |
6.7 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 1.3 |
12.0 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 1.3 |
5.3 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 1.3 |
2.6 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 1.3 |
29.1 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 1.3 |
8.8 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 1.2 |
18.6 |
GO:0001660 |
fever generation(GO:0001660) |
| 1.2 |
6.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.2 |
8.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 1.2 |
4.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.2 |
3.6 |
GO:1902722 |
positive regulation of prolactin secretion(GO:1902722) |
| 1.2 |
13.0 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 1.2 |
3.5 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.2 |
7.0 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 1.2 |
4.6 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 1.1 |
4.6 |
GO:1904800 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.1 |
2.2 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 1.1 |
3.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 1.1 |
3.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 1.1 |
16.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 1.1 |
6.6 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 1.1 |
12.0 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 1.1 |
1.1 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 1.1 |
10.9 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 1.1 |
2.2 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 1.1 |
4.3 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) |
| 1.0 |
1.0 |
GO:0002763 |
positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 1.0 |
2.1 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.0 |
6.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 1.0 |
10.3 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 1.0 |
8.2 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 1.0 |
11.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 1.0 |
2.0 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 1.0 |
3.0 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 1.0 |
11.1 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.0 |
4.0 |
GO:0044147 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 1.0 |
67.7 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 1.0 |
9.8 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.0 |
2.9 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.0 |
4.9 |
GO:0003051 |
angiotensin-mediated drinking behavior(GO:0003051) |
| 1.0 |
4.9 |
GO:0021557 |
optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 1.0 |
5.8 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 1.0 |
3.9 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 1.0 |
26.0 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 1.0 |
6.7 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 1.0 |
7.7 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.0 |
2.9 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 1.0 |
6.7 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 1.0 |
12.4 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.9 |
3.8 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.9 |
5.6 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.9 |
5.5 |
GO:0030421 |
defecation(GO:0030421) |
| 0.9 |
14.7 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.9 |
2.7 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.9 |
30.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.9 |
3.6 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.9 |
3.6 |
GO:0070895 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.9 |
2.7 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.9 |
5.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.9 |
3.6 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.9 |
2.7 |
GO:0014059 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.9 |
2.7 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.9 |
3.6 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.9 |
0.9 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.9 |
7.0 |
GO:1905068 |
arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.9 |
44.7 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.9 |
0.9 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.9 |
6.0 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) |
| 0.9 |
2.6 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.9 |
0.9 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.9 |
12.8 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.8 |
4.2 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.8 |
1.7 |
GO:0006067 |
ethanol metabolic process(GO:0006067) |
| 0.8 |
2.5 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.8 |
5.0 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.8 |
3.3 |
GO:0060168 |
regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.8 |
2.5 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.8 |
0.8 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.8 |
5.0 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.8 |
3.3 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.8 |
4.1 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.8 |
4.9 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.8 |
2.4 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.8 |
7.2 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.8 |
0.8 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.8 |
3.2 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.8 |
4.0 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.8 |
18.3 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.8 |
3.2 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.8 |
6.3 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.8 |
3.9 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.8 |
15.7 |
GO:1904259 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.8 |
1.6 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.8 |
1.5 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.8 |
1.5 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.8 |
4.6 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.8 |
19.9 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.8 |
6.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.8 |
0.8 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.8 |
12.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.8 |
0.8 |
GO:0051784 |
negative regulation of nuclear division(GO:0051784) |
| 0.8 |
3.0 |
GO:2000434 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.7 |
1.5 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 0.7 |
13.4 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.7 |
3.0 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.7 |
2.2 |
GO:1903674 |
regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.7 |
3.7 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.7 |
3.7 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) |
| 0.7 |
2.9 |
GO:0060935 |
cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.7 |
5.8 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.7 |
1.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.7 |
2.2 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.7 |
2.2 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.7 |
2.2 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.7 |
5.8 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 |
2.2 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.7 |
4.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.7 |
7.1 |
GO:1900825 |
regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.7 |
4.3 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.7 |
7.1 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.7 |
2.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.7 |
1.4 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.7 |
2.1 |
GO:0032917 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.7 |
1.4 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.7 |
4.2 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.7 |
34.0 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.7 |
3.5 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.7 |
6.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.7 |
3.4 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.7 |
3.4 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.7 |
2.0 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.7 |
1.3 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.7 |
2.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.7 |
5.3 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.7 |
34.3 |
GO:0032732 |
positive regulation of interleukin-1 production(GO:0032732) |
| 0.7 |
0.7 |
GO:1901532 |
regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 0.7 |
10.5 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.7 |
3.9 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.7 |
2.0 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.6 |
5.8 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.6 |
4.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.6 |
0.6 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.6 |
1.9 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.6 |
2.6 |
GO:0042441 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.6 |
3.2 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.6 |
3.2 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.6 |
0.6 |
GO:1902339 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.6 |
1.9 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.6 |
2.5 |
GO:1903045 |
neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
| 0.6 |
1.9 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 |
8.8 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.6 |
1.9 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.6 |
0.6 |
GO:0015965 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.6 |
3.1 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.6 |
1.2 |
GO:0035905 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.6 |
7.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.6 |
0.6 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.6 |
6.1 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.6 |
1.8 |
GO:0072738 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.6 |
1.8 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.6 |
3.1 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.6 |
12.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.6 |
4.8 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.6 |
1.8 |
GO:0070637 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.6 |
7.8 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.6 |
2.4 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.6 |
1.2 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.6 |
2.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.6 |
6.0 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.6 |
3.6 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.6 |
2.4 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.6 |
1.2 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.6 |
21.2 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.6 |
10.0 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.6 |
1.8 |
GO:0019364 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.6 |
2.3 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.6 |
5.8 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.6 |
1.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.6 |
7.6 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.6 |
1.7 |
GO:0033007 |
negative regulation of mast cell activation involved in immune response(GO:0033007) |
| 0.6 |
4.1 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.6 |
4.1 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.6 |
2.3 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.6 |
2.9 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.6 |
3.5 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.6 |
6.9 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.6 |
9.7 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.6 |
2.9 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.6 |
1.1 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.6 |
2.8 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.6 |
2.8 |
GO:2000639 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.6 |
3.9 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.6 |
5.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.6 |
1.7 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.6 |
0.6 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.6 |
0.6 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.6 |
2.8 |
GO:1901545 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.6 |
2.2 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.5 |
1.6 |
GO:0097325 |
melanocyte proliferation(GO:0097325) |
| 0.5 |
0.5 |
GO:0060021 |
palate development(GO:0060021) |
| 0.5 |
0.5 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.5 |
5.9 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.5 |
4.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.5 |
1.6 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.5 |
4.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.5 |
1.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 |
3.2 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.5 |
9.0 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.5 |
6.9 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.5 |
1.6 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.5 |
22.8 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.5 |
2.1 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.5 |
9.0 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.5 |
1.0 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.5 |
2.1 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.5 |
2.6 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.5 |
0.5 |
GO:1903094 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.5 |
2.1 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.5 |
3.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 |
7.3 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
0.5 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.5 |
1.6 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.5 |
2.6 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.5 |
0.5 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.5 |
4.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.5 |
7.2 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.5 |
0.5 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.5 |
3.6 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.5 |
1.5 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.5 |
4.6 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.5 |
1.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 |
6.0 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.5 |
4.0 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.5 |
1.5 |
GO:1900106 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 |
0.5 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.5 |
2.5 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.5 |
3.9 |
GO:0014717 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.5 |
1.0 |
GO:2000318 |
positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.5 |
1.0 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.5 |
2.9 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.5 |
0.5 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.5 |
0.5 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.5 |
1.9 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.5 |
1.4 |
GO:0006043 |
glucosamine catabolic process(GO:0006043) |
| 0.5 |
9.1 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.5 |
2.4 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.5 |
0.5 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.5 |
4.8 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.5 |
15.2 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.5 |
9.5 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.5 |
4.7 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.5 |
0.9 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.5 |
5.2 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.5 |
2.4 |
GO:1990910 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.5 |
1.9 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.5 |
5.2 |
GO:0099639 |
neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.5 |
1.4 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.5 |
3.3 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.5 |
0.5 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.5 |
2.3 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.5 |
6.9 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.5 |
0.5 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.5 |
1.4 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.5 |
1.8 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.5 |
0.5 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.4 |
0.4 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.4 |
2.2 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.4 |
3.1 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 |
0.9 |
GO:2000742 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.4 |
0.4 |
GO:0042222 |
interleukin-1 biosynthetic process(GO:0042222) |
| 0.4 |
6.7 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.4 |
1.3 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.4 |
2.7 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.4 |
4.9 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.4 |
2.2 |
GO:0070944 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.4 |
2.2 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.4 |
6.6 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.4 |
1.8 |
GO:0010909 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.4 |
7.4 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.4 |
1.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.4 |
0.4 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.4 |
1.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.4 |
0.4 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.4 |
1.7 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.4 |
1.3 |
GO:0072616 |
interleukin-18 secretion(GO:0072616) |
| 0.4 |
1.7 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.4 |
1.7 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.4 |
3.0 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
1.7 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.4 |
3.0 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.4 |
0.9 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) |
| 0.4 |
3.0 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.4 |
4.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.4 |
1.3 |
GO:1905216 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.4 |
2.1 |
GO:0071442 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.4 |
10.5 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.4 |
0.4 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.4 |
1.3 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.4 |
1.7 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.4 |
1.3 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.4 |
3.3 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.4 |
4.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.4 |
5.0 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.4 |
1.2 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.4 |
3.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.4 |
4.5 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 |
1.6 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.4 |
4.1 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.4 |
2.9 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.4 |
2.0 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 |
1.2 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.4 |
0.8 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 |
2.8 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.4 |
3.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.4 |
5.7 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.4 |
4.0 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.4 |
0.8 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.4 |
4.0 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.4 |
3.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 |
0.8 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.4 |
0.8 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.4 |
4.7 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.4 |
2.0 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 |
4.3 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 |
0.8 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.4 |
1.6 |
GO:0090094 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.4 |
3.5 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.4 |
5.4 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 |
0.8 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.4 |
0.8 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.4 |
3.1 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 |
0.8 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.4 |
7.7 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.4 |
0.8 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.4 |
1.5 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.4 |
2.6 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.4 |
1.9 |
GO:0021778 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.4 |
2.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.4 |
2.6 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.4 |
1.1 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.4 |
0.8 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.4 |
1.5 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 |
7.5 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.4 |
3.4 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.4 |
3.0 |
GO:0060751 |
epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.4 |
1.1 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.4 |
4.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.4 |
0.4 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.4 |
4.1 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.4 |
2.6 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.4 |
4.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.4 |
4.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.4 |
5.5 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.4 |
4.4 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.4 |
0.4 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.4 |
2.6 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.4 |
1.8 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.4 |
1.8 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.4 |
1.5 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.4 |
2.2 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.4 |
4.6 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.4 |
1.1 |
GO:0044861 |
protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
| 0.4 |
2.5 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.4 |
4.3 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.4 |
0.4 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.4 |
3.2 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.4 |
1.4 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.4 |
0.7 |
GO:0001842 |
neural fold formation(GO:0001842) B-1 B cell homeostasis(GO:0001922) neural fold elevation formation(GO:0021502) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
| 0.4 |
2.8 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.4 |
1.4 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
3.2 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.4 |
1.1 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.4 |
2.8 |
GO:0046087 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.3 |
4.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.3 |
0.7 |
GO:0097205 |
glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.3 |
3.8 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.3 |
1.0 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.3 |
1.4 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.3 |
1.4 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
1.0 |
GO:0046963 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.3 |
2.7 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 |
1.0 |
GO:0071226 |
response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.3 |
0.7 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.3 |
2.7 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.3 |
1.7 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.3 |
6.1 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.3 |
4.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 |
1.0 |
GO:1903033 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.3 |
1.0 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.3 |
0.7 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.3 |
2.7 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.3 |
4.7 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.3 |
0.3 |
GO:1903306 |
negative regulation of regulated secretory pathway(GO:1903306) |
| 0.3 |
0.7 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.3 |
3.3 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.3 |
0.7 |
GO:1904502 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.3 |
1.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
1.3 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.3 |
0.3 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 |
0.7 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
| 0.3 |
1.6 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.3 |
1.3 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.3 |
2.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 |
1.6 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.3 |
2.3 |
GO:1990592 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.3 |
3.2 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.3 |
5.5 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.3 |
1.3 |
GO:0016334 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.3 |
4.5 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.3 |
6.4 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.3 |
0.3 |
GO:0060702 |
negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.3 |
2.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
1.6 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
1.3 |
GO:0033080 |
immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 |
4.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 |
1.6 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 |
1.3 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.3 |
1.3 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.3 |
1.0 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.3 |
0.3 |
GO:1900543 |
negative regulation of purine nucleotide metabolic process(GO:1900543) |
| 0.3 |
1.0 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.3 |
11.7 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.3 |
0.9 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.3 |
0.6 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.3 |
1.6 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.3 |
4.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.3 |
20.6 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.3 |
1.9 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 |
0.6 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.3 |
0.3 |
GO:0035878 |
nail development(GO:0035878) |
| 0.3 |
0.9 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.3 |
1.5 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.3 |
0.6 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.3 |
3.7 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.3 |
0.9 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 |
1.8 |
GO:0052173 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) response to host(GO:0075136) |
| 0.3 |
1.5 |
GO:0035513 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.3 |
0.9 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
1.5 |
GO:0000956 |
nuclear-transcribed mRNA catabolic process(GO:0000956) |
| 0.3 |
0.9 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.3 |
2.1 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.3 |
1.5 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.3 |
4.5 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.3 |
1.2 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 |
1.5 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.3 |
0.9 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.3 |
0.6 |
GO:0010266 |
response to vitamin B1(GO:0010266) cellular response to lead ion(GO:0071284) |
| 0.3 |
1.8 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 |
3.6 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.3 |
1.8 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.3 |
0.6 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.3 |
0.3 |
GO:0061356 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
| 0.3 |
2.9 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
14.6 |
GO:0042531 |
positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.3 |
3.2 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.3 |
0.9 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.3 |
0.3 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.3 |
28.3 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.3 |
0.6 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.3 |
0.3 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
21.0 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.3 |
4.0 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.3 |
1.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
2.9 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.3 |
0.6 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.3 |
0.6 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.3 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 |
8.0 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 |
0.3 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.3 |
1.7 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.3 |
0.6 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.3 |
0.8 |
GO:0019836 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.3 |
2.0 |
GO:0098704 |
fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.3 |
0.8 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
1.1 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.3 |
2.5 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 |
0.8 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.3 |
1.9 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.3 |
2.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 |
0.6 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.3 |
7.7 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.3 |
3.6 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.3 |
22.0 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.3 |
3.6 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.3 |
0.8 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.3 |
0.8 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.3 |
3.6 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.3 |
3.0 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 |
0.8 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.3 |
3.0 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.3 |
0.5 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.3 |
5.7 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 |
1.6 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.3 |
0.5 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.3 |
3.8 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.3 |
0.8 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.3 |
1.6 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.3 |
1.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
4.3 |
GO:0032620 |
interleukin-17 production(GO:0032620) |
| 0.3 |
8.3 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.3 |
2.1 |
GO:0061053 |
somite development(GO:0061053) |
| 0.3 |
3.5 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.3 |
1.1 |
GO:0044728 |
DNA methylation or demethylation(GO:0044728) |
| 0.3 |
4.8 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.3 |
0.8 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
| 0.3 |
3.4 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.3 |
0.8 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.3 |
0.5 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 |
0.3 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.3 |
6.0 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.3 |
2.6 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
1.0 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.3 |
0.5 |
GO:0034776 |
response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.3 |
1.6 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 |
0.5 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.3 |
2.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 |
1.0 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
1.3 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.3 |
28.6 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.3 |
1.3 |
GO:1904383 |
response to sodium phosphate(GO:1904383) |
| 0.3 |
7.9 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
0.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
7.9 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.3 |
1.5 |
GO:0035376 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.3 |
4.8 |
GO:0060004 |
reflex(GO:0060004) |
| 0.3 |
3.8 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.3 |
0.8 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
2.0 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
4.8 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.3 |
0.8 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 |
6.5 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.3 |
2.8 |
GO:1904903 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.3 |
1.3 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.3 |
0.8 |
GO:0023058 |
adaptation of signaling pathway(GO:0023058) |
| 0.3 |
2.5 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.3 |
0.8 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.2 |
0.5 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 |
1.2 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 |
0.7 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.2 |
1.0 |
GO:1990144 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.2 |
2.2 |
GO:0035733 |
hepatic stellate cell activation(GO:0035733) fibroblast activation(GO:0072537) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
1.0 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
3.7 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.2 |
3.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
4.6 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 |
1.7 |
GO:0046449 |
creatinine metabolic process(GO:0046449) |
| 0.2 |
2.7 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.2 |
2.7 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.2 |
3.1 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.2 |
1.9 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
3.9 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
1.0 |
GO:1900175 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.2 |
1.0 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 |
2.4 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.2 |
0.5 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.2 |
1.7 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
0.7 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.2 |
0.2 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.2 |
0.7 |
GO:0006171 |
cAMP biosynthetic process(GO:0006171) |
| 0.2 |
2.6 |
GO:0090487 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.2 |
2.3 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
1.6 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.2 |
0.2 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.2 |
0.2 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.2 |
0.7 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.2 |
0.2 |
GO:0099638 |
endosome to plasma membrane protein transport(GO:0099638) |
| 0.2 |
0.9 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 |
3.7 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.2 |
0.2 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.2 |
0.9 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.2 |
1.1 |
GO:0002792 |
negative regulation of peptide secretion(GO:0002792) |
| 0.2 |
0.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
1.4 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.2 |
1.1 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.2 |
0.2 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 |
0.5 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.2 |
2.0 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.2 |
0.9 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.2 |
2.9 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.2 |
0.9 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.2 |
1.5 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.2 |
7.1 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.2 |
1.5 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.2 |
0.9 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.2 |
1.1 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 |
2.6 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.2 |
0.7 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.2 |
1.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
0.4 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.2 |
1.9 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
1.3 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 |
0.9 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.2 |
2.3 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.2 |
3.6 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.2 |
0.8 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 |
1.5 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.2 |
8.9 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.2 |
1.5 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
0.4 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 |
0.6 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.2 |
0.4 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
1.0 |
GO:0070669 |
interleukin-2-mediated signaling pathway(GO:0038110) response to interleukin-2(GO:0070669) cellular response to interleukin-2(GO:0071352) |
| 0.2 |
0.8 |
GO:0002003 |
angiotensin maturation(GO:0002003) |
| 0.2 |
5.4 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 |
0.2 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.2 |
0.2 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.2 |
0.8 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.2 |
2.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
0.8 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 |
0.6 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.2 |
0.6 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 |
10.8 |
GO:0042267 |
natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.2 |
1.9 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.2 |
0.2 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.2 |
2.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
1.0 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 |
14.7 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.2 |
1.0 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
0.6 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
3.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
0.6 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 |
6.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.2 |
0.4 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.2 |
1.0 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 |
0.8 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.2 |
2.8 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.2 |
1.0 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.2 |
1.4 |
GO:0015824 |
proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.2 |
6.2 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.2 |
0.8 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
0.2 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 |
1.0 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 |
1.0 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.2 |
0.6 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.2 |
1.2 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 |
1.0 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
0.2 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.2 |
0.8 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
2.9 |
GO:0070072 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 |
0.8 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
0.6 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.2 |
4.8 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.2 |
2.5 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.2 |
0.2 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.2 |
1.0 |
GO:0045196 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
0.4 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.2 |
0.8 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
4.9 |
GO:1901687 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 |
1.3 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.2 |
1.5 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 |
0.4 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.2 |
0.4 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
0.8 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.6 |
GO:0014744 |
positive regulation of muscle adaptation(GO:0014744) |
| 0.2 |
0.6 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.2 |
0.4 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 |
5.6 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.2 |
0.7 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 |
2.6 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 |
1.5 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.2 |
0.9 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.2 |
9.5 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
0.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.9 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.2 |
1.6 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
0.4 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 |
2.3 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.2 |
1.3 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 |
1.8 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.2 |
0.7 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.2 |
2.0 |
GO:0032324 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.2 |
4.3 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.2 |
0.2 |
GO:0032714 |
negative regulation of interleukin-5 production(GO:0032714) |
| 0.2 |
1.2 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.2 |
1.2 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.2 |
0.2 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.2 |
1.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 |
5.4 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.2 |
1.9 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.2 |
7.6 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
0.3 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.2 |
0.7 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.2 |
1.4 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.2 |
0.5 |
GO:0006900 |
membrane budding(GO:0006900) |
| 0.2 |
0.5 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.2 |
0.8 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
1.3 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.2 |
2.0 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
1.7 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 |
1.5 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.2 |
1.5 |
GO:0046549 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 |
1.7 |
GO:0071499 |
cellular response to laminar fluid shear stress(GO:0071499) |
| 0.2 |
1.3 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.2 |
1.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.2 |
1.0 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.2 |
1.8 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.5 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
2.0 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
1.0 |
GO:0043542 |
endothelial cell migration(GO:0043542) |
| 0.2 |
0.8 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.2 |
0.6 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
0.2 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.2 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
5.6 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 |
1.3 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.2 |
0.3 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.2 |
0.2 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 |
0.2 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 |
0.9 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 |
5.1 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.2 |
0.6 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.2 |
1.2 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.2 |
0.3 |
GO:0036017 |
response to erythropoietin(GO:0036017) |
| 0.2 |
2.6 |
GO:0022011 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 |
0.3 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.2 |
1.5 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
0.8 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
0.5 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.2 |
13.9 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
0.2 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.4 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
1.3 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.4 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.1 |
2.2 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
2.4 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 |
0.9 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.7 |
GO:0003373 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 |
1.5 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 |
0.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.4 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.1 |
0.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
0.9 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 |
0.3 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.1 |
0.7 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
0.9 |
GO:0034628 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.9 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.1 |
1.2 |
GO:0035303 |
regulation of dephosphorylation(GO:0035303) |
| 0.1 |
1.4 |
GO:0038127 |
ERBB signaling pathway(GO:0038127) |
| 0.1 |
0.3 |
GO:1904350 |
regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.1 |
0.3 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.1 |
1.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 |
0.8 |
GO:0086068 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.1 |
1.0 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
1.0 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.1 |
0.7 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.4 |
GO:1905229 |
thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.1 |
0.6 |
GO:0021563 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 |
0.3 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
2.1 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 |
2.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.1 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.1 |
0.8 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.1 |
0.7 |
GO:0034182 |
regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
2.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.5 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.4 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.1 |
0.5 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 |
0.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
3.0 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
1.1 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
1.8 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.1 |
0.4 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.1 |
0.1 |
GO:0001890 |
placenta development(GO:0001890) |
| 0.1 |
0.4 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.3 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.5 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
0.4 |
GO:0021697 |
cerebellar cortex formation(GO:0021697) |
| 0.1 |
0.4 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.1 |
1.1 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.4 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.1 |
1.2 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.1 |
0.5 |
GO:0033082 |
extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 |
2.4 |
GO:0002320 |
lymphoid progenitor cell differentiation(GO:0002320) |
| 0.1 |
6.3 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.5 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.5 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.1 |
0.4 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 |
0.9 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.1 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 |
0.3 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
0.4 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 |
0.1 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 |
0.9 |
GO:1903959 |
regulation of anion transmembrane transport(GO:1903959) |
| 0.1 |
1.3 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.4 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 |
0.9 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.1 |
0.4 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
6.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
3.8 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.5 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
1.2 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.4 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.1 |
0.6 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.1 |
1.0 |
GO:0031629 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 |
0.2 |
GO:0070350 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.1 |
1.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
1.1 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.2 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.1 |
0.2 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 |
0.2 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.1 |
1.2 |
GO:0045916 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.1 |
0.7 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.6 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.1 |
GO:0021897 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 |
0.1 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 0.1 |
0.2 |
GO:1903960 |
negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.1 |
0.2 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.1 |
0.3 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.1 |
1.0 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
0.3 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
1.4 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.1 |
0.1 |
GO:0043200 |
response to amino acid(GO:0043200) |
| 0.1 |
0.4 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.1 |
6.4 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
1.0 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.1 |
0.4 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 |
2.1 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.1 |
0.9 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.3 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.1 |
GO:0042509 |
regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
| 0.1 |
0.1 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.1 |
0.8 |
GO:1905038 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 |
2.6 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.8 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
2.5 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
1.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.1 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.1 |
0.2 |
GO:0098868 |
endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.1 |
0.8 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.1 |
1.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.1 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
3.2 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 |
0.8 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
8.7 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.7 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.7 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
2.1 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
2.4 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
1.2 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.4 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
3.5 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 |
0.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.1 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.1 |
0.4 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
0.3 |
GO:1901535 |
regulation of DNA demethylation(GO:1901535) |
| 0.1 |
0.1 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
2.1 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.1 |
1.0 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
0.3 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.3 |
GO:0002371 |
dendritic cell cytokine production(GO:0002371) myeloid dendritic cell cytokine production(GO:0002372) |
| 0.1 |
3.3 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.2 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.8 |
GO:0030204 |
proteoglycan metabolic process(GO:0006029) chondroitin sulfate metabolic process(GO:0030204) chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
| 0.1 |
0.6 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.1 |
0.3 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
3.9 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 |
8.5 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.1 |
0.7 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 |
0.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.4 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.1 |
0.3 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.2 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
0.1 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) |
| 0.1 |
1.5 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.3 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.7 |
GO:0010224 |
response to UV-B(GO:0010224) |
| 0.1 |
3.5 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.7 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.1 |
0.1 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.8 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.1 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.1 |
1.4 |
GO:0048705 |
skeletal system morphogenesis(GO:0048705) |
| 0.1 |
0.3 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.1 |
0.4 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.5 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.3 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.3 |
GO:0030187 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.4 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.1 |
0.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 |
0.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
1.1 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.1 |
0.4 |
GO:0016128 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 |
0.1 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.1 |
0.2 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.3 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 |
0.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.9 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.3 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 |
1.9 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.1 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.2 |
GO:1904238 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
| 0.1 |
1.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
1.6 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.1 |
0.6 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.1 |
0.7 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.2 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.1 |
0.2 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
0.4 |
GO:1902961 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 |
0.2 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.4 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.2 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
1.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.3 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
0.1 |
GO:0002921 |
negative regulation of humoral immune response(GO:0002921) |
| 0.1 |
0.2 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.7 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
0.3 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.1 |
1.3 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.2 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.1 |
3.1 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.5 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
1.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.2 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 |
1.6 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 |
0.2 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
0.2 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.1 |
0.5 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 0.1 |
0.5 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 |
0.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.3 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
2.0 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 |
0.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.1 |
1.1 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.4 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
0.2 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 |
0.9 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.1 |
0.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.1 |
1.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
1.7 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 |
10.0 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.1 |
0.8 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.1 |
GO:1903214 |
regulation of protein targeting to mitochondrion(GO:1903214) |
| 0.1 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.4 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.4 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.1 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.4 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
0.4 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
0.3 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 |
1.1 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.5 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.3 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 |
0.1 |
GO:1903708 |
positive regulation of hemopoiesis(GO:1903708) |
| 0.1 |
0.3 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 |
0.6 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.8 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.3 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.1 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.1 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
2.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
0.3 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.1 |
0.5 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.2 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.9 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.1 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.3 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.6 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.1 |
0.3 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.6 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
2.4 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.5 |
GO:0031087 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.1 |
GO:2000296 |
negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.1 |
0.4 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.3 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
0.1 |
GO:0018393 |
internal peptidyl-lysine acetylation(GO:0018393) |
| 0.1 |
0.1 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.1 |
1.1 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.1 |
0.2 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 |
0.2 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.5 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.9 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.2 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 |
0.2 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.1 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.1 |
0.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.6 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) |
| 0.1 |
0.9 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.5 |
GO:0030038 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.1 |
0.1 |
GO:0055006 |
cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.5 |
GO:2000425 |
regulation of apoptotic cell clearance(GO:2000425) |
| 0.1 |
0.3 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.1 |
GO:0051142 |
regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.1 |
0.4 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.5 |
GO:0046006 |
regulation of activated T cell proliferation(GO:0046006) |
| 0.1 |
0.6 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.5 |
GO:0002251 |
organ or tissue specific immune response(GO:0002251) |
| 0.1 |
0.6 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
0.2 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 |
0.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.9 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.2 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.1 |
0.6 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.8 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
0.3 |
GO:0002228 |
natural killer cell mediated immunity(GO:0002228) |
| 0.1 |
0.2 |
GO:1900125 |
negative regulation of interleukin-12 biosynthetic process(GO:0045083) regulation of hyaluronan biosynthetic process(GO:1900125) positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 |
0.1 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.2 |
GO:0061383 |
trabecula morphogenesis(GO:0061383) |
| 0.1 |
0.4 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.6 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.1 |
0.2 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
2.1 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 |
0.2 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.1 |
1.6 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.7 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
| 0.1 |
0.3 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 |
0.4 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
1.9 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.4 |
GO:1990089 |
response to nerve growth factor(GO:1990089) |
| 0.1 |
0.8 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
1.8 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.1 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 0.1 |
0.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.1 |
0.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
0.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
5.2 |
GO:0070268 |
cornification(GO:0070268) |
| 0.1 |
0.5 |
GO:0060039 |
pericardium development(GO:0060039) |
| 0.1 |
0.1 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 |
0.1 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
1.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.1 |
0.1 |
GO:0051645 |
Golgi localization(GO:0051645) |
| 0.1 |
0.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
0.9 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
2.0 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.4 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.0 |
0.1 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.0 |
0.4 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
1.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.3 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 |
0.1 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.5 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.0 |
0.2 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
0.2 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
0.0 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.0 |
0.5 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.1 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 |
0.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
1.0 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
4.1 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.3 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.1 |
GO:0009206 |
purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.0 |
0.1 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.3 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.0 |
0.1 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.0 |
0.2 |
GO:0046373 |
arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.0 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.0 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
3.2 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.0 |
0.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.6 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.0 |
0.4 |
GO:0045901 |
positive regulation of translational elongation(GO:0045901) |
| 0.0 |
0.3 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.7 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.0 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.0 |
0.3 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
0.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.2 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.0 |
0.3 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.0 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.0 |
0.1 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.0 |
1.7 |
GO:0000272 |
polysaccharide catabolic process(GO:0000272) |
| 0.0 |
0.2 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 |
0.2 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) |
| 0.0 |
0.2 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.0 |
GO:1901534 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.0 |
0.1 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.2 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.0 |
0.2 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.1 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 |
0.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.0 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.6 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.0 |
0.0 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.2 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 |
0.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.3 |
GO:0048639 |
positive regulation of developmental growth(GO:0048639) |
| 0.0 |
0.0 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.2 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.0 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.0 |
0.1 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.0 |
0.2 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
1.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.7 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
1.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.4 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.9 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.4 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.1 |
GO:0040029 |
regulation of gene expression, epigenetic(GO:0040029) |
| 0.0 |
0.2 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.0 |
0.2 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 |
0.1 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.2 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.0 |
0.1 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.0 |
0.2 |
GO:0003323 |
type B pancreatic cell development(GO:0003323) |
| 0.0 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 |
0.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 |
0.1 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 |
0.6 |
GO:0002456 |
T cell mediated immunity(GO:0002456) |
| 0.0 |
0.1 |
GO:0050432 |
catecholamine secretion(GO:0050432) |
| 0.0 |
0.1 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.0 |
0.3 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.3 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.1 |
GO:0048260 |
positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.2 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.0 |
0.2 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.0 |
0.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.0 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.5 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.2 |
GO:0033151 |
V(D)J recombination(GO:0033151) |
| 0.0 |
0.5 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.0 |
0.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.1 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.1 |
GO:0032639 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.0 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.0 |
2.4 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.2 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.2 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.3 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.5 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.2 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.2 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 |
0.1 |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.0 |
0.1 |
GO:0030042 |
actin filament depolymerization(GO:0030042) |
| 0.0 |
0.1 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 0.0 |
0.0 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.2 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.3 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.3 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.0 |
0.2 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.0 |
0.4 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.4 |
GO:0006817 |
phosphate ion transport(GO:0006817) phosphate ion transmembrane transport(GO:0035435) |
| 0.0 |
0.5 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
0.3 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.4 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.1 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.0 |
0.1 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.7 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.1 |
GO:0044144 |
modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.0 |
0.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.1 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.0 |
0.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.1 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.0 |
0.1 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.0 |
GO:1903299 |
regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 0.0 |
1.7 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.1 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.1 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.0 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 |
0.1 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.0 |
0.1 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
0.4 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.0 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.0 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.0 |
0.3 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.1 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.1 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.0 |
0.2 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.1 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.0 |
0.1 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 |
0.3 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.1 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.0 |
0.2 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
| 0.0 |
0.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.0 |
GO:0045912 |
negative regulation of carbohydrate metabolic process(GO:0045912) |
| 0.0 |
0.0 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.4 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.0 |
0.4 |
GO:0006337 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
| 0.0 |
0.0 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.0 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.4 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.1 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.4 |
GO:0021762 |
substantia nigra development(GO:0021762) |
| 0.0 |
0.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.0 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
0.0 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.1 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
